Piper Therapeutics Inc. is a pre-clinical drug discovery company developing therapies that affect inflammatory signaling and immune system response, with applications to immuno-oncology, sepsis and automimmune disorders.
Piper Therapeutics Inc.
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/piper-therapeutics-inc” connections=”true” suffix=””]
Piper Therapeutics is developing molecules to influence the tumor microenvironment to prevent tumor transformation of inflammatory and immune cells into pro-cancer support cells.
In Sep 2015, Piper Therapeutics raised about $1.50 Mn in debt financing.